Dr Hal Gunn demonstrates administration QBECO SSI

Magic of Qu Crohn’s Panel Discussion

Dr. Hal Gunn demonstrates to patients how to administer QBECO SSI, an investigational new treatment for Crohn’s disease. Qu is actively recruiting 60 adults with moderate to severe Crohn’s disease for a Phase 1/2 of this potential new treatment. Qu Biologics develops Site Specific (SSIs), a novel class of immunotherapies that aim to ‘reboot’ the body’s .

Leave a Reply